Molecular Oncology
Volume 2, Issue 2 , Pages 153-160, August 2008

Innovations, challenges and future prospects of oncoproteomics

Jain PharmaBiotech, Bläsiring 7, CH-4057 Basel, Switzerland

Received 20 April 2008; received in revised form 8 May 2008; accepted 20 May 2008. published online 16 June 2008.

Abstract 

Oncoproteomics is playing an increasingly important role in the diagnosis and management of cancer as well as in the development of personalized treatment of cancer. Innovative proteomic technologies relevant to cancer are described briefly, which are helping in the understanding of mechanism of drug resistance in cancer and will provide some leads to improve the management. Most important of these are nanoproteomics, i.e. application of nanobiotechnology to proteomics is playing an important role in nanooncology. Examples of some cancers will be given to point out the challenges and future prospects of oncoproteomics including those involving translation of technologies from the bench to the bedside.

Keywords: Cancer biomarkers, Nanobiotechnology, Nanooncology, Oncoproteomics, Personalized medicine, Proteomics

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1574-7891(08)00069-0

doi:10.1016/j.molonc.2008.05.003

Molecular Oncology
Volume 2, Issue 2 , Pages 153-160, August 2008